Blepharochalasis right eye, unspecified eyelid
ICD-10 H02.33 is a billable code used to indicate a diagnosis of blepharochalasis right eye, unspecified eyelid.
Blepharochalasis is characterized by the recurrent swelling of the eyelids, leading to excess skin and laxity, particularly affecting the right eye in this case. The condition typically presents with episodes of eyelid edema, which may resolve but leave behind redundant skin. The anatomy involved includes the eyelid structures, such as the skin, orbicularis oculi muscle, and underlying connective tissue. The lacrimal system may also be affected, as the swelling can obstruct normal tear drainage, leading to epiphora (excessive tearing). Disease progression can vary; while some patients may experience intermittent episodes, others may develop persistent eyelid sagging that affects vision and aesthetics. Diagnostic considerations include a thorough clinical examination, patient history, and possibly imaging studies to rule out other orbital or eyelid disorders. It is essential to differentiate blepharochalasis from other eyelid conditions such as ptosis or dermatochalasis, which may require different management approaches.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H02.33 specifically covers blepharochalasis affecting the right eye, which may include recurrent eyelid swelling and resultant skin laxity. It is important to document the frequency and severity of episodes to support the diagnosis.
H02.33 should be used when the condition specifically affects the right eyelid and is characterized by recurrent swelling and skin laxity. It is crucial to differentiate it from other eyelid conditions like ptosis or dermatochalasis.
Documentation should include a detailed history of the eyelid condition, clinical findings during examination, and any imaging studies if performed. Notes should clearly describe the nature of the swelling and its impact on the patient's vision or quality of life.
